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Abstract 
Patients with pre-surgery cognitive impairment cannot currently be assessed for cognitive 
recovery after surgery using the Postoperative Quality of Recovery Scale (PostopQRS),as 
they would mathematically be scored as recovered. The group nonetheless represent a frail 
cohort at high risk of recovering poorly. We aimed to validate a novel method to score 
cognitive recovery in patients with low baseline cognition, using the number of low-score 
tests rather than their numerical values. Face validity was demonstrated in 86 participants 
in whom both PostopQRS and an 11-item neuropsychological battery were performed. The 
PostopQRS agreed with neuropsychological categorization of low versus normal cognition 
74% of the time, with all but 5 incorrectly coded participants deviating by only 1 
neurocognitive test. Cognitive recovery over time was comparable for groups with differing 
baseline cognitive function, irrespective of whether PostopQRS or neuropsychological 
methods were used.  Discriminant validation was demonstrated in a post hoc analysis of the 
Steroids in Cardiac Surgery (SIRS) substudy by allocating groups to normal (n=246) or low 
baseline cognition (n=231) stratified by cognitive recovery on day 1. Recovery was similar 
for participants with low and normal baseline cognition. Postoperative length of stay was 
longer in patients with failed cognitive recovery whether they had normal (10.4±10.0 vs. 
8.0±5.9 days, P=0.02) or low baseline cognition (12.0±11.1 vs. 8.2±4.7 days, P<0.01). Overall 
quality of recovery, as well as cognitive, emotive, and physiological recovery in those who 
recovered was independent of baseline cognition. The modified scoring method for the 
PostopQRS cognitive domain therefore demonstrates acceptable face and discriminant 
validity.  
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Introduction 
Post-operative cognitive dysfunction (POCD) is associated with serious morbidity and 
mortality (1-5). Cognitive decline is common after major surgery (6-9), particularly in the 
elderly (3, 8), making cognitive recovery an important determinant of overall long-term 
surgical outcome. Early detection of cognitive recovery may alert health care practitioners 
to the risk of poor overall recovery and possibly provide opportunity for early intervention. 
The Postoperative Quality of Recovery Scale (PostopQRS) is a multidimensional survey-
based tool, which includes a domain designed to measure cognitive recovery over time 
during the postoperative period (10). The cognitive domain includes five verbal cognitive 
tests. The other domains are physiological, emotive, nociceptive, and activities of daily 
living. The Scale also includes an overall patient perspective domain.  
Generally, the instrument is administered preoperatively to provide individual baseline 
measurements for each patient. Thereafter, recovery in various domains is defined by 
postoperative values equaling or exceeding individual baseline values, except for the 
cognitive domain where a tolerance level is added to adjust for normal performance 
variability (11).  That is, patients can perform a little worse than baseline in the cognitive 
domain, by the magnitude of the tolerance factor, and still be scored as recovered. 
Currently, patients whose preoperative performance is so low such that any postoperative 
performance will fall within the tolerance factor are considered to have a low baseline 
performance in that test. A consequence of having low baseline cognition on a test 
preoperatively is that these patients will be automatically scored as “recovered” when 
assessed postoperatively for these tests.  Accordingly, participants with low baseline 
cognition are not currently scored in the cognitive domain postoperatively, although they 
can be scored in other recovery domains. 
The difficulty is that patients with pre-existing cognitive impairment are at especially great 
risk of poor outcomes, especially if their cognition further worsens (1, 2, 12). To address this 
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limitation of the PostopQRS, we developed a novel scoring method for cognitive recovery in 
patients with low baseline scores in the cognitive domain. Specifically, we now consider the 
number of cognitive tests (out of 5) on which a patient performs poorly preoperatively (i.e. 
below the test’s threshold value for low baseline cognition). Postoperative recovery in this 
population is then defined as the same number of tests or fewer that score below the 
threshold value. If more tests score below the threshold values than occurred 
preoperatively, then cognitive recovery has not occurred..  Our aim was to demonstrate 
both face and discriminant validity for this modified scoring method.  
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Methods 
We used two existing datasets. The first was from a single-centre observational study 
“Comparison of neurocognitive assessment vs. PostopQRS cognitive domain performance to 
assess cognitive recovery in patients undergoing cardiac surgery.” conducted at the Royal 
Melbourne Hospital, Australia (Melbourne Health HREC 2011.142). It included 69 cardiac 
surgery patients, each of whom had both PostopQRS and a comprehensive neurocognitive 
test battery. The second was from the Steroids In caRdiac Surgery trial (SIRS) substudy 
Quality of Recovery sub-study (13). All participants understood and spoke English well 
enough to complete the testing surveys, and none had known psychiatric disease, dementia, 
or any medical or learning disorder that would impair cognitive ability.  
In each study, patients were assessed preoperatively and at multiple postoperative times. 
We compared cognitive recovery in patients who had normal or low cognitive baseline and 
determined whether clinical outcomes (quality of patient recovery, length of stay, 
cardiovascular complications, surgical complications and death) differed for participants 
who did and did not demonstrate cognitive recovery on the first postoperative day.  
Scoring cognitive recovery using the PostopQRS 
The cognitive domain of the PostopQRS consists of 5 verbal cognitive tests: orientation, 
digits forward, digits back, word recall, and word generation. Cognition is deemed 
recovered when scores on all five tests return to within a small delta (‘tolerance factor’) of 
baseline values. The tolerance factors for the cognitive subdomains are 0/3 for orientation, 
2/6 for digits forward, 1/6 for digits back and 3/15 for word recall, and 3/unlimited for word 
generation (11).  
Because patients whose initial cognitive performance on any test is less than the allowed 
tolerance are automatically scored as recovered postoperatively with the original scoring 
approach, we modified our scoring system for patients whose preoperative cognitive 
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function was poor, with poor being defined by an initial score within the tolerance range on 
any of the 5 cognitive tests. Specifically, the modified system considers the number of 
cognitive tests on which patients scores below the tolerance range preoperatively. Patients 
are then considered recovered postoperatively when they score poorly on no more tests 
than they did preoperatively.  For example, patient who had 1 low baseline cognitive test 
preoperatively will be scored as recovered if they perform poorly on no more than any 1 of 
the 5 cognitive tests postoperatively, but not if they have low performance on 2 or more of 
the tests. 
Face validation: Comparison of neurocognitive assessment vs. PostopQRS cognitive 
domain performance to assess cognitive recovery in patients undergoing cardiac surgery. 
We determined face validity by comparing low versus normal baseline patients using an 11-
item neurocognitive battery as the reference method. Face validity was considered to have 
been established if cognitive recovery was similar for low and normal baseline cohorts using 
each method. 
The PostopQRS and the neuropsychological battery tests were performed by trained 
research staff. The PostopQRS interviews were conducted face-to-face while patients were 
hospitalized or via telephone after discharge (11).The neurocognitive testing coincided with 
the corresponding face-to-face PostopQRS interviews, with both tests being performed by 
the same research team member. Baseline PostopQRS and neurocognitive baseline data 
collection occurred no more than 14 days prior to surgery. Subsequent PostopQRS data 
collection occurred on postoperative day 1, days 3-5, day 14, day 30, and weeks 6-8. 
Postoperative neurocognitive testing occurred at postoperative days 3-5 and weeks 6-8. 
Each test was carried out by a trained research member, with blinding occurring at data 
entry and analysis. 
The neuropsychological battery included 11 validated and widely utilised neurocognitive 
tests that assessed domains recommended in the Consensus Statement on postoperative 
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neurobehavioral outcomes (14, 15).Test outcomes were either time to test completion 
(Trails A & B and Grooved Pegboard) or number of correct responses (Controlled Oral Word 
Association Test, Stroop Colour Word Test, Rey Auditory Verbal Learning Test, Longest Digit 
Span (Forward and Backward) and Symbol Digit Modality). Where appropriate, reference 
parameters of these tests were age and sex matched and parallel forms containing different 
word and number lists were used  in order to reduce learning effect   (16-18). 
The analysis of the neuropsychological tests was conducted as follows.  
1. A literature search was conducted to identify age- and sex-matched reference values for 
each test (mean and standard deviation), which were used as reference values to 
standardize each participant's test performance and are shown in Table S1. 
2.  Baseline neuropsychological performance was determined by comparison of the 
participant’s preoperative neuropsychological test scores to that of the age- and sex-
matched population norms (16-18), expressed as Z scores (standard deviations from the 
mean). Baseline neuropsychological cognition was considered poor when patients had a 
normalized Z scores less than -1.96 in at least two of the 11 tests in the battery which is 
consistent with PostopQRS scoring in patients were categorized as having low baseline 
cognition when they had a low baseline score in at least one of the 5 tests in the battery, as 
well as current definitions of poor neuropsychological performance  
Comparison between the PostopQRS tests of cognition and Neuropsychological 
Assessment regarding those with adequate and poor baseline cognition.. 
1. The number of tests in which a patient achieved normal baseline scores was compared 
for both neuropsychological and PostopQRS tests. This process quantified agreement 
between the reference neuropsychological method and the PostopQRS in categorizing low 
versus normal baseline participants. 
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2. Cognitive recovery in the PostopQRS domain was calculated using the current scoring 
method for normal baseline participants, and the modified scoring method for low-baseline 
participants.  
3. PostopQRS cognitive recovery, as defined by both PostopQRS and neurocognitive testing, 
was compared in normal and low-baseline participants using Cochran–Mantel–Haenszel 
tests.  We were thus able to determine whether cognitive recover, as measured by the 
PostopQRS, was similar amongst groups classified as having low versus normal baseline 
cognition.  
4. A reverse analysis was also performed. Neuropsychological recovery was graphed for 
days 3-5 and weeks 6-8 for both low and normal baseline groups, with baseline group 
classification being determined both by the PostopQRS and neuropsychological definitions.  
This approach allowed us to determine whether neuropsychological recovery was similarly 
define by PostopQRS and neuropsychological definitions of low versus normal baseline 
cognition.   
Discriminant validation: The impact of early cognitive recovery after cardiac: an analysis 
of the SIRS trial substudy (13) 
To investigate discriminant validation, we hypothesised that quality-of-recovery as well as 
clinical outcomes (length of stay, cardiovascular complications, surgical complications and 
death) would be worse in patients who failed to recover early (day 1) in the cognitive 
domain, compared to those patients who did had early cognitive recovery, independent of 
whether they had low or normal baseline cognitive function.  
This sub-study was a part of the Steroids In SIRS trial ClinicalTrials.gov identifier 
NCT00427388).(19) The sub-study started well after the underlying trial began, and was 
restricted to the Royal Melbourne Hospital (Australia), the Cleveland Clinic (USA), and the 
Hamilton Health Sciences and McMaster University (Canada). Amendments to the SIRS 
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ethics approvals and local governance approvals were obtained at each participating centre 
to conduct this substudy. 
A detailed description of the underlying SIRS trial was published (19).  In brief, it was a 
double-blinded, placebo-controlled, randomised multicentre trial on high-risk, cardiac 
surgery participants (EuroSCORE ≥6). The intervention was to administer 250 mg of 
methylprednisolone at anaesthetic induction and a further 250 mg just prior to 
commencement of cardiopulmonary bypass.  
The PostopQRS was conducted within 2 weeks before surgery (baseline) and 1 day, 2 days, 3 
days, 1 month, and 6 months after surgery. The physiological subdomain was only measured 
on postoperative days 1 to 3. The results of the comparison between methylprednisolone 
and placebo have been previously reported and showed no difference between groups (20).  
In this analysis, the participants were therefore combined.  
Cognitive recovery was scored using the current method for participants with normal 
baseline scores and using the modified scoring system for participants with low baseline 
scores (see above). Two groups were defined post hoc according to the presence or absence 
of cognitive recovery on day 1 after surgery. 
The primary outcome used to determine discriminant validation was length of hospital stay 
after cardiac surgery. Secondary outcomes used to support discriminant validation included 
other clinical adverse events, including death, atrial fibrillation, myocardial infarction, 
stroke, acute kidney injury, and infections within 6 months after cardiac surgery as well as 
failure to recover in the overall domain and the physiological, nociceptive, emotive, 
functional, and cognitive subdomains over 6 months following cardiac surgery. 
Continuous data are presented as means ± standard deviations, binary data are presented 
as absolute numbers and percentages of participants, and odds ratios are displayed with 
95% confidence intervals (CI). Differences in clinical events were assessed using students t-
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tests for continuous data and chi-squared tests for binary data. In terms of quality of 
recovery over time, differences between groups were assessed using the Cochrane-Mantel-
Haenszel test. In case of a significant difference between groups in quality of recovery over 
time, chi-squared tests were used to compare the proportions of participants recovered at 
each individual time point. Statistical analysis was not performed for the evaluation of 
severity of incomplete cognitive recovery due to an inadequate sample size to exclude Type 
II error.   
P-values <0.05 were considered statistically significant. All p-values are two-sided. 
Descriptive data were stored in Microsoft Excel 2016 (Microsoft Corp., CA, USA), statistical 
analyses were performed using Stata/IC 12.1 for Mac (Stata Corp., TX, USA), and data were 
graphically described in Graph Pad Prism 6 (GraphPad Software, La Jolla, CA, USA). A sample 
size was determined by the number of participants assessed with the PostopQRS in the SIRS 
studies so no formal sample size estimates were performed.  
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Results 
Face validation: Comparison of neurocognitive assessment vs. PostopQRS cognitive 
domain performance to assess cognitive recovery in patients undergoing cardiac surgery 
Sixty-nine participants were enrolled, but two were excluded because of incomplete data. 
Eighteen participants (27%) had low baseline PostopQRS cognition.  Demographic and 
operative data are shown in Table S2.   
For each participant, the number of tests that were scored as normal for both PostopQRS 
and for neuropsychological batteries are shown in Figure 1. There was agreement in 
categorisation in 74% of participants. Where categorization differed, the magnitude of 
difference was 1 test on the neuropsychological battery in all but 5 participants.  Among the 
11 patients who had normal PostopQRS baseline but low neuropsychological baseline, 9 
failed in at least one motor test. Of those with normal neuropsychological baseline but low 
PostopQRS cognition, 4/6 failed one neuropsychological verbal test.  
Cognitive recovery in the PostopQRS domain is shown for normal and low baseline 
participants in Figure 2. Cognitive recovery was similar for normal and low baseline 
participants, irrespective of the definition used to categorise low baseline participants. 
Neuropsychological recovery on days 3-4 and at 6-8 weeks is shown in Figure 3. Recovery in 
the normal baseline group was similar to that in the low baseline group, irrespective of the 
definition used to categorise low baseline participants.  
Discriminant validation: The impact of early cognitive recovery after cardiac: an analysis 
of the SIRS trial substudy (13)  
From January 2012 to December 2013, 555 participants were enrolled of whom 48 had 
incomplete baseline scores and 27 participants had missing follow-up data on the first day 
after surgery. There were thus 482 participants available for data analyses (246 normal 
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cognitive baseline and 234 low cognitive baseline, Figure S1). In participants with normal 
baseline cognitive scores 79/246 participants, and for low baseline cognition 89/234 
participants were cognitively recovered on the first postoperative day.  
Recovery for normal and low baseline cognition groups 
Baseline characteristics and operative details are shown in Table S3. Mean ages were 
72 ± 12 years in the cognitively recovered group, and 72 ± 11 years in the non-recovered 
group. Generally, the cognitively recovered and non-recovered participants were similar 
although there was a tendency towards a higher proportion of active smokers among the 
non-recovered participants. The normal and the low baseline groups were similar except the 
tendency towards higher age in the low baseline group.  
A comparison of recovery in all domains of the PostopQRS, using the modified scoring 
system for low baseline cognition, is shown for all participants with normal and low baseline 
cognition in shown in Figure S2. The low baseline group had slightly better cognitive 
recovery, but with a similar profile across time to the patients with normal baseline 
cognition.  Recovery profiles did not differ significantly in any other domains.   
Participants with normal cognitive baseline scores 
Clinical outcomes of participants with normal cognitive baseline scores are displayed in 
Table 1. The total length of hospitalization in the cognitive recovered group was 8.0 ± 5.9 vs. 
10.4 ± 10.0 days, p=0.02). The proportion of participants with a length of stay beyond 10 
days was 13% in the recovered group versus 25% in the non-recovered group, (odds ratio: 
2.4, 95% CI 1.1-5.0, p=0.02). Length-of-stay in the intensive care unit (ICU) was 2.1 ± 3.0 
days versus 3.2 ± 5.5 days, p=0.049; and the proportion of participants with a length of ICU 
stay beyond 2 days was 14% in the recovered group, which was lower than 34% in the non-
recovered group, (odds ratio: 3.1, 95% CI 1.5-6.3, p=0.01). There were no differences 
between groups in any of the other outcomes. 
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Quality of recovery over time to 6 months after surgery in normal baseline cognition 
participants is shown for cognitive recovered versus not recovered groups in Figure 4. The 
incidence of overall recovery was higher for recovered compared to non-recovered 
participants, p<0.01. The cognitive and physiological domains showed better recovery for 
the recovered group (p<0.01), but not emotive, nociceptive or functional recovery.  
Participants with low cognitive baseline scores 
The clinical outcomes for participants with low baseline cognitive scores are shown in 
Table 2. The total length of stay was shorter in the cognitive recovered group (8.2 ± 4.7 vs. 
12.0 ± 11.1 days, p<0.01), as was the proportion of participants with a length of stay beyond 
10 days (16% vs. 37%, p<0.01, odds ratio: 3.2, 95% CI 1.7-6.2). Length of ICU stay was 
shorter in the cognitive recovered group (2.4 ± 2.5 vs. 3.9 ± 4.7, p<0.01), as was the 
proportion of participants with a length of ICU stay beyond 2 days (19% vs. 42%, p<0.01, 
odds ratio: 3.1, 95% CI 1.7-5.8). In addition, the incidence of death at 30 days after 
randomization was lower in cognitively recovered participants (1% vs. 9%, p=0.01). The 
groups were generally similar in terms of the other adverse outcomes. 
Quality of recovery over time for patients with low cognitive baseline scores is illustrated in 
Fig. 5. Overall recovery was higher in the recovered group (p<0.01). Cognitive, physiological 
and emotive recovery was higher in the recovered group (all p<0.01), whereas there were 
no differences between the groups in terms of nociception or activity of daily living. 
Severity of cognitive recovery failure 
The recovery profiles for participants with normal cognitive baseline scores based on the 
number of tests where recovery had failed, are shown in Figure S3 and participants with low 
cognitive baseline scores are displayed in Figure S4. Generally, recovery was worse in 
patients with poor baseline cognitive function, especially in the cognitive, physiological, and 
overall recovery domains.   
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Discussion  
Face validity implies that the test responds as expected and includes construct validity 
where tests measuring similar constructs should produce similar results (21). The 
PostopQRS agreed with neuropsychological categorisation of low versus normal baseline 
cognition in most participants. Importantly, where disagreement occurred, it was usually by 
a small margin on 1 test on the neuropsychological battery. This is unsurprising, as 
PostopQRS cognitive tests are derivatives of the neuropsychological battery, with a focus on 
brief, verbal tests designed to facilitate telephone use (11). The 11–item battery includes 
visuospatial and motor tests in addition to the verbal tests, and though they essentially 
measure similar constructs, the motor tests assess cognitive performance in areas that the 
PostopQRS does not.  
Most participants with normal baseline PostopQRS but low baseline neuropsychological 
cognition failed at least one motor test, whereas the majority of low baseline 
PostopRQS/normal baseline neuropsychological participants failed a single verbal test. It is 
of note that motor tests are not included in the PostopQRS Cognitive subtests.  We 
demonstrated further face validity by showing that cognitive recovery was similar for both 
low and normal baseline cohorts, whether or not PostopQRS or neurocognitive methods 
were used to categorise low baseline cognition. We included a reverse analysis, and showed 
face validity that a neurocognitive definition of recovery was comparable in normal- and 
low-baseline participants, irrespective of the method used to categorize low baseline.  
Recovery improved over time in both normal and low baseline groups in a manner that is 
consistent with previous data (10, 11, 22-25), indicating that the new scoring system 
produces similar results in low baseline participants to the normal baseline participants. This 
similarity of cognitive recovery between groups that have normal vs. low baseline cognition 
has potentially important clinical implications given the current debate regarding the 
relationship between pre-existing cognitive impairment and poor postoperative cognitive 
function (1, 3, 26-29), and emphasises the need to validate a scoring system with which to 
measure cognitive recovery in those patients with a low preoperative baseline.  
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We demonstrated discriminant validity for the modified scoring system using the SIRS trial 
substudy data (13). Quality of recovery in the SIRS trial was similar in normal and low 
baseline participants for domains other than cognition (which could previously not be 
scored for the low baseline group). But when the modified cognitive scoring was applied to 
the low baseline participants, and groups were allocated according to cognitive recovery on 
day 1,  then the differences in clinical and quality of recovery outcomes in both low and 
normal baseline groups were similar, favouring early cognitive recovery.  Discriminant 
validity was further demonstrated by a pattern of increasingly worse recovery as the 
number of tests failed at baseline increased, indicating a severity effect.  
Our primary aim was to validate a new scoring method for cognitive recovery in patients 
with low baseline cognition. The cohort study comparing PostopQRS and 
neuropsychological test was sufficient to demonstrate face validity, but too small to 
evaluate clinical outcomes. In the clinical trial, we allocated groups according to cognitive 
recovery on day 1, and hence, only participants who completed the PostopQRS at Day 1 
were included in these analyses. It is possible that participants who declined to complete 
the assessment at this time point had a worse outcome introducing a potential inclusion 
bias. The sample size in this sub study was determined by the number of participants 
assessed with the PostopQRS in the SIRS study, and it was not a priori powered for the post 
hoc analysis to detect potential differences between low and normal cognitive baseline 
scores. Comparison of these groups was used to test for discriminant validation of the 
proposed scoring system for low baseline patients, rather than to assess the importance of 
early cognitive recovery, and we  urge caution in further analysis of these data. However, 
whether early detection of cognitive failure provides a window-of-opportunity for 
interventions that might improve outcomes, merits further research.  
In summary, patients with low baseline cognitive function are a high-risk group that may 
especially benefit from postoperative cognitive assessment. Our modified scoring method 
for the Postoperative Quality of Recovery Scale cognitive domain demonstrates acceptable 
face and discriminant validity which supports using the test in patients with baseline 
cognitive impairment.    
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Online supporting information 
Table S1.  Age and gender matched values for the neuropsychological tests. LDSF – Longest 
Digit Span Forward; LDSB – Longest Digital Span Backward; Trail A & B – Trail Tests A & B; 
COWAT – Controlled Oral Word Association Test; SCWT – Stroop Colour Word Test – 
Interference (Trennery); GP-Dom – Grooved Pegboard, dominant hand; GP-NonDom  - 
Grooved Pegboard, non-dominant hand; RAVLT 1-5 – Rey Auditory Verbal Learning Test, 
total (tests 1-5); RAVLT – Recall - Rey Auditory Verbal Learning Test, recall; SDMT – Symbol 
Digit Modality Test. 
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Table S2. Demographic and operative details for the face validation study “Comparison of 
neurocognitive assessment vs. PostopQRS cognitive domain performance to assess 
cognitive recovery in patients undergoing cardiac surgery.” 
. 
Table S3. Characteristics and operative details of cardiac surgery patients (SIRS substudy) 
with either normal or low cognitive baseline scores. 
Figure S1. Participant flow diagram for the SIRS substudy.  
Figure S2. Recovery over time is shown for the SIRS substudy cohort categorized by normal 
or low baseline cognition. 
Figure S3. Recovery over time is shown for the SIRS substudy cohort with normal baseline 
cognition, and categorized according to the number of tests that the participants failed 
recovery. 
Figure S4. Recovery over time is shown for the SIRS substudy cohort with low baseline 
cognition, and categorized according to the number of tests that the participants failed 
recovery. 
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Table 1. Clinical outcomes of cardiac surgery patients with normal cognitive baseline scores  
 Recovered  
at Day 1 
n = 79 
Nonrecovered 
at Day 1 
         n = 167 
Odds 
ratio 
(95% CI) 
P- 
value 
Length of stay     
Postoperative stay, days  8.0 ± 5.9 10.4 ± 10.0  0.02 
<10 days, n (%) 69 (87) 124 (74)  
2.4 
(1.1-5.0) 
 
11 to 16 days, n (%) 8 (10) 24 (14) 0.03 
>17 days, n (%) 2 (3) 19 (11)  
ICU stay, days 2.1 ± 3.0 3.2 ± 5.5  0.049 
<2 days, n (%) 68 (86) 111 (66)  
3.1 
(1.5-6.3) 
 
0.01 3 to 5 days, n (%) 7 (9) 40 (24) 
>6 days, n (%) 4 (5) 16 (10) 
Adverse outcomes     
Death, n (%)  3 (4) 10 (6) 1.6 
(0.5-5.6) 
0.47 
 22 
Atrial fibrillation, n (%)   27 (34) 63 (38) 1.2 
(0.7-2.0) 
0.59 
Myocardial infarction, n (%) 24 (30) 72 (43) 1.7 
(1.0-3.1) 
0.06 
Stroke, n (%) 2 (3) 6 (4) 1.4 
(0-3.1) 
0.66 
Acute kidney injury, n (%) 10 (13) 34 (20) 1.8 
(0.8-3.7) 
0.14 
Normal function, n (%) 69 (87) 133 (80)  
 
1.8 
(0.8-3.7) 
 
Risk, n (%) 5 (6) 19 (11)  
Injury, n (%) 4 (5) 9 (5) 0.51 
Failure, n (%) 1 (1) 3 (2) 
Loss of function, n (%) 0 (0) 0 (0)  
End-stage disease, n (%) 0 (0) 3 (2)  
Surgical site infection, n (%) 3 (4) 15 (9) 1.6 0.15 
 23 
(0.7-3.6) 
Other infection, n (%) 8 (10) 25 (15) 2.5 
(0.7-8.3) 
0.30 
 
Status of recovery refers to the cognitive subdomain on the first postoperative day, and renal 
function is defined according to the RIFLE criteria. Odds ratios and confidence intervals are 
calculated as superiority of cognitive recovery to cognitive non-recovery at first postoperative 
day i.e. an odds ratio of more than 1 indicates superiority of recovery, whereas an odds ratio 
of less than 1 indicates superiority of non-recovery. Data reported as means ± standard 
deviations or absolute numbers and percentages of patients. ICU, intensive care unit; CI, 
confidence interval 
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Table 2. Clinical outcomes of cardiac surgery patients with low cognitive baseline scores  
 Recovered 
at Day 1 
n = 89 
Non-recovered 
at Day 1 
n = 142 
Odds 
ratio 
(95% CI) 
P- 
value 
Length of stay     
Postoperative stay, days  8.2 ± 4.7 12.0 ± 11.1  <0.01 
<10 days, n (%) 75 (84) 89 (63)  
3.2 
(1.7-6.2) 
 
11 to 16 days, n (%) 9 (10) 30 (21) <0.01 
>17 days, n (%) 5 (6) 23 (16)  
ICU stay, days 2.4 ± 2.5 3.9 ± 4.7  <0.01 
<2 days, n (%) 72 (81) 82 (58)  
3.1 
(1.7-5.8) 
<0.01 3 to 5 days, n (%) 9 (10) 38 (27) 
>6 days, n (%) 8 (9) 22 (15) 
Adverse outcomes     
Death, n (%)  1 (1) 13 (9) - 0.01 
 25 
Atrial fibrillation, n (%)   33 (37) 51 (36) 1.0 
(0.6-1.6) 
0.86 
Myocardial infarction, n (%) 33 (37) 58 (41) 1.2 
(0.7-2.0) 
0.57 
Stroke, n (%) 1 (1) 2 (1) - 0.85 
Acute kidney injury, n (%) 19 (21) 30 (21) 0.99 
(0.5-1.9) 
0.97 
Normal function, n (%) 70 (79) 112 (79) 
0.99 
(0.5-1.9) 
 
Risk, n (%) 11 (12) 16 (11)  
Injury, n (%) 3 (3) 5 (4) 0.98 
Failure, n (%) 2 (2) 5 (4) 
Loss of function, n (%) 0 (0) 0 (0)  
End-stage disease, n (%) 3 (3) 4 (3)  
Surgical site infection, n (%) 1 (1) 12 (8) - 0.02 
Other infection, n (%) 7 (8) 32 (23) 3.4 <0.01 
 26 
(1.5-7.9) 
 
Status of recovery refers to the cognitive subdomain on the first postoperative day, and renal 
function is defined according to the RIFLE criteria. Odds ratios and confidence intervals are 
calculated as superiority of cognitive recovery to cognitive non-recovery at first postoperative 
day i.e. an odds ratio of more than 1 indicates superiority of recovery, whereas an odds ratio 
of less than 1 indicates superiority of non-recovery. Data reported as means ± standard 
deviations or absolute numbers and percentages of patients. ICU, intensive care unit; CI, 
confidence interval; -, odds ratio cannot be calculated due to low number of events  
 
 
  
 27 
Figure Legends 
Figure 1. The number of tests that were scored above the cut-off values for low baseline 
cognition are shown for the 11-item neuropsychological better (Y axis) and the PostopQRS 
(X axis). The cut off for low baseline cognition is £ 9 neuropsychological, or £4 PostopQRS 
tests.  
Figure 2. The proportion of participants who recovered in the PostopQRS cognitive domain 
is shown over time for participants with low and normal baseline cognition. Low baseline 
cognition is categorised by both PostopQRS and neuropsychological definitions..   
Figure 3. The proportion of participants who recovered using neuropsychological criteria is 
shown over time for participants with low and normal baseline cognition. Low baseline 
cognition is categorised by both PostopQRS and neuropsychological.   
Figure 4. Recovery over time is shown for the SIRS substudy cohort in participants with 
normal baseline cognition, categorized by the presence or absence of cognitive recovery on 
Day 1 after surgery. 
Figure 5. Recovery over time is shown for the SIRS substudy cohort in participants with low 
baseline cognition, categorized by the presence or absence of cognitive recovery on Day 1 
after surgery. 
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